RESPIRATORY TRACT NEOPLASMS
Clinical trials for RESPIRATORY TRACT NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY TRACT NEOPLASMS trials appear
Sign up with your email to follow new studies for RESPIRATORY TRACT NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug offered to lung cancer patients out of options
Disease control NO_LONGER_AVAILABLEThis program provides access to the experimental drug taletrectinib for adults with advanced ROS1-positive lung cancer who have run out of approved treatment options and cannot join regular clinical trials. The drug aims to control cancer growth in patients who have already tried…
Matched conditions: RESPIRATORY TRACT NEOPLASMS
Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Apr 01, 2026 22:55 UTC
-
Real-World test for advanced lung cancer treatment combo
Disease control OngoingThis study is observing how well a combination of the drug Osimertinib and standard chemotherapy works for people with a specific type of advanced lung cancer (EGFR-positive NSCLC) in a real-world setting. It involves 532 adult patients who have already started this specific trea…
Matched conditions: RESPIRATORY TRACT NEOPLASMS
Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Can better doctor training save more lung cancer patients?
Knowledge-focused OngoingThis study aims to see if providing standardized training to cancer doctors in smaller city and county hospitals leads to better testing and treatment for patients with advanced non-small cell lung cancer. It will follow 1,000 patients to measure if doctors order more recommended…
Matched conditions: RESPIRATORY TRACT NEOPLASMS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC